BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cladribine

An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.

297+ PubMed studies analyzed · 21 RCTs · Evidence Score: 54.2

Research Domains

Cladribine has been studied across 9 research domains including 🛡️ Immunity, 😴 Sleep, 🔬 Oncology, ⏳ Longevity & Aging, 🔬 Inflammation. The primary research focus is 🛡️ Immunity with 56% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cladribine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Trifluridine
16 shared targets
Melphalan
18 shared targets
Clofarabine
16 shared targets
Ciclopirox
17 shared targets
Dinitrochlorobenzene
17 shared targets
cycloheximide
23 shared targets
Mycophenolic
14 shared targets
Cytarabine
12 shared targets
Isopentenyladenosine
11 shared targets
Desoxycorticosterone
12 shared targets
Loading evidence profile...

This evidence profile for Cladribine is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.